소화기계 일반의약품 시장 보고서(2026년)

Gastrointestinal over-the-counter (OTC) drugs are non-prescription medications used to prevent or manage common digestive issues. They provide convenient and fast relief for conditions like indigestion, nausea, constipation, or diarrhea, helping maintain digestive comfort and overall gastrointestinal wellness.

The main product types of gastrointestinal OTC drugs include antacids, laxatives, anti-diarrheals, anti-emetics, and others. Antacids work by neutralizing stomach acid to relieve heartburn and indigestion. These drugs are available in various formulations, including tablets, capsules, and liquids, and are used for indications such as heartburn, diarrhea, constipation, gastroesophageal reflux disease (GERD), nausea, vomiting, motion sickness, and more. They are distributed through multiple channels, including direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others, serving end users such as hospitals, clinics, home healthcare, and general consumers.

Tariffs have raised costs in the gastrointestinal OTC drugs market by affecting imports of active ingredients, excipients, and packaging materials. Antacids, laxatives, and anti-diarrheal products are most impacted, especially in Asia-Pacific and North America where global sourcing is common. Retail and online pharmacies experience margin pressure. Positively, tariffs are promoting regional production of digestive health medicines and OTC formulations.

The gastrointestinal over-the-counter (otc) drugs market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal over-the-counter (otc) drugs market statistics, including gastrointestinal over-the-counter (otc) drugs industry global market size, regional shares, competitors with a gastrointestinal over-the-counter (otc) drugs market share, detailed gastrointestinal over-the-counter (otc) drugs market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal over-the-counter (otc) drugs industry. This gastrointestinal over-the-counter (otc) drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastrointestinal over-the-counter (otc) drugs market size has grown strongly in recent years. It will grow from $49.59 billion in 2025 to $53.74 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to digestive disorder prevalence, otc drug accessibility, pharmacy retail expansion, urban lifestyle changes, dietary habit shifts.

The gastrointestinal over-the-counter (otc) drugs market size is expected to see strong growth in the next few years. It will grow to $73.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to preventive digestive care adoption, e-commerce growth, clean-label otc demand, aging population, digestive health awareness. Major trends in the forecast period include rising self-medication for digestive disorders, growing demand for fast-acting otc relief, increased use of combination gastrointestinal products, expansion of online pharmacy sales, growing preference for herbal and enzyme-based products.

The increasing prevalence of digestive disorders is expected to drive the growth of the gastrointestinal OTC drugs market going forward. Digestive disorders encompass a range of conditions affecting the gastrointestinal tract, including the stomach, intestines, and associated organs. The rise in digestive disorders is primarily due to higher consumption of processed, low-fiber foods, which disrupt gut health and impair digestion. Gastrointestinal OTC drugs help manage digestive disorder symptoms by reducing stomach acid, regulating bowel movements, and supporting overall gut health. They offer fast and convenient relief from common issues such as acidity, constipation, and indigestion. For instance, in December 2023, according to the IBD Registry Ltd., a UK-based non-profit organization, the number of individuals with inflammatory bowel disease (IBD) exceeded 5,300, marking an increase of more than 3,000 members compared to 2022. Therefore, the increasing prevalence of digestive disorders is driving the growth of the gastrointestinal OTC drugs market.

Major companies operating in the gastrointestinal OTC drugs market are focusing on developing advanced products, such as over-the-counter (OTC) proton pump inhibitors (PPIs), to provide effective and long-lasting relief from acid-related disorders. OTC PPIs are medications available without a prescription that reduce stomach acid production, commonly used to treat conditions like frequent heartburn, gastroesophageal reflux disease (GERD), and gastric ulcers. For instance, in March 2025, Eisai Co., Ltd., a Japan-based pharmaceutical company, received approval in Japan to switch its Pariet S (rabeprazole sodium 10 mg) from prescription (Rx) to OTC status, making it the first OTC PPI in Japan with the same active ingredient and dosage as its prescription counterpart. Pariet S is indicated for stomach pain, heartburn, and bloating, offering 24-hour relief with a once-daily, easy-to-swallow tablet, addressing the growing need for effective acid-related treatments amid lifestyle and demographic changes.

In July 2024, Cooper Consumer Health SAS, a France-based consumer healthcare company, acquired Viatris Inc.'s OTC business for an undisclosed amount. This acquisition allows Cooper Consumer Health to expand its presence across key European markets and double its revenues by adding over 200 well-known OTC brands in therapeutic areas including gastrointestinal care, feminine hygiene, antiseptics, and cholesterol management. Viatris Inc. is a US-based healthcare company specializing in gastrointestinal OTC drugs.

Major companies operating in the gastrointestinal over-the-counter (otc) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd.

North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal over-the-counter (otc) drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastrointestinal over-the-counter (otc) drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastrointestinal over-the-counter (OTC) drugs market consists of sales of digestive enzymes, probiotics, stool softeners, and fiber supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastrointestinal Over-The-Counter (OTC) Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses gastrointestinal over-the-counter (otc) drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastrointestinal over-the-counter (otc) drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastrointestinal over-the-counter (otc) drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Antacid; Laxatives; Anti-Diarrheal; Anti-Emetics; Other Products
• 2) By Formulation: Tablets; Capsules; Liquids; Other Formulations
• 3) By Indications: Heartburn; Diarrhoea; Constipation; Gastroesophageal Reflux Disease (GERD); Nausea; Vomiting; Motion Sickness; Other Indications
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
• 5) By End-Users: Hospitals; Clinics; Home Healthcare; Other End-Users
• Subsegments:
• 1) By Antacid: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists; Calcium Carbonate; Magnesium Hydroxide; Sodium Bicarbonate; Combination Antacids
• 2) By Laxatives: Bulk-Forming Laxatives; Stimulant Laxatives; Osmotic Laxatives; Stool Softeners; Lubricant Laxatives
• 3) By Anti-Diarrheal: Loperamide; Bismuth Subsalicylate; Probiotics; Electrolyte Solutions
• 4) By Anti-Emetics: Antihistamines; Bismuth Subsalicylate; Phosphorated Carbohydrate Solution; Ginger Supplements
• 5) By Other Products: Digestive Enzymes; Simethicone; Herbal Remedies; Activated Charcoal
• Companies Mentioned: Pfizer Inc.; Procter & Gamble Co.; Johnson & Johnson; Merck & Co. Inc.; Bayer AG; Novartis AG; Sanofi S.A.; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Ltd.; Reckitt Benckiser Group plc; Boehringer Ingelheim GmbH; Haleon plc; Sandoz AG; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Ltd.; Perrigo Company plc; Dr. Reddy's Laboratories Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Gastrointestinal Over-The-Counter (OTC) Drugs Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Gastrointestinal Over-The-Counter (OTC) Drugs Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Sustainability, Climate Tech & Circular Economy
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Rising Self-Medication For Digestive Disorders
  • 4.2.2 Growing Demand For Fast-Acting Otc Relief
  • 4.2.3 Increased Use Of Combination Gastrointestinal Products
  • 4.2.4 Expansion Of Online Pharmacy Sales
  • 4.2.5 Growing Preference For Herbal And Enzyme-Based Products

5. Gastrointestinal Over-The-Counter (OTC) Drugs Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Home Healthcare
• 5.4 Retail Pharmacies
• 5.5 Online Consumers

6. Gastrointestinal Over-The-Counter (OTC) Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastrointestinal Over-The-Counter (OTC) Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Gastrointestinal Over-The-Counter (OTC) Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastrointestinal Over-The-Counter (OTC) Drugs Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastrointestinal Over-The-Counter (OTC) Drugs Market Segmentation

• 9.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products
• 9.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tablets, Capsules, Liquids, Other Formulations
• 9.3. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications
• 9.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
• 9.5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Home Healthcare, Other End-Users
• 9.6. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Antacid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids
• 9.7. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives
• 9.8. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Diarrheal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions
• 9.9. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Emetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements
• 9.10. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Digestive Enzymes, Simethicone, Herbal Remedies, Activated Charcoal

10. Gastrointestinal Over-The-Counter (OTC) Drugs Market Regional And Country Analysis

• 10.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 11.1. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 12.1. China Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 13.1. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 14.1. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 15.1. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 16.1. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 17.1. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 18.1. Taiwan Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 19.1. South East Asia Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 20.1. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 21.1. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 22.1. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 23.1. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 24.1. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 25.1. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 26.1. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 27.1. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 28.1. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 29.1. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 30.1. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 31.1. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 32.1. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 33.1. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 34.1. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastrointestinal Over-The-Counter (OTC) Drugs Market Regulatory and Investment Landscape

36. Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Landscape And Company Profiles

• 36.1. Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Gastrointestinal Over-The-Counter (OTC) Drugs Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Gastrointestinal Over-The-Counter (OTC) Drugs Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Procter & Gamble Co. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Gastrointestinal Over-The-Counter (OTC) Drugs Market Other Major And Innovative Companies

• Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd.

38. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastrointestinal Over-The-Counter (OTC) Drugs Market

40. Gastrointestinal Over-The-Counter (OTC) Drugs Market High Potential Countries, Segments and Strategies

• 40.1 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer